Effect of 2LMISEN® on Long-Term Hippocampal Neurons Culture as a Screening Senescent Cells Model: p16INK4A and Caspase 3 Quantification

The aim of the present study was to investigate the effect of one capsule of the micro-immunotherapy medicine (MIM) 2LMISEN® compared to vehicle, in a neuronal aging model. Senescence and apoptosis of hippocampal neurons were evaluated by measuring p16INK4a and caspase 3 levels, respectively. The data presented is a single observation. Mice hippocampal neuron cultures were treated with MIM (11 mM) or vehicle (11 mM) from 22 days in vitro (DIV) until 27 DIV. After incubation, hippocampal neuron cultures were fixed at 15 (control condition), 22, 25 and 27 DIV and then incubated with primary antibodies p16INK4a, MAP2 and Caspase 3. Quantification of p16INK4a and Caspase 3-positive neurons was done using Developer software. We found that vehicle had no effect on p16INK4a expression, whereas MIM was able to decrease p16INK4a levels at 22, 25 and 27 DIV in a statistically significant manner. The MIM had no significative effect on Caspase 3 expression. Our preliminary results showed that the MIM capsule significantly reduced neuronal senescence and not apoptosis.


Introduction
The concept of cellular senescence was first introduced by Hayflick  sions [1]. During normal organism aging, cells undergo a wide range of structural and functional changes, including senescence and apoptosis [2]. Even though they have been proposed to contribute to the development of certain age-related diseases, senescence and apoptosis are critically important for the function of many tissues [3] [4]. Senescent cells undergo a durable growth arrest, associated with the expression of anti-proliferative molecules (such as p16 INK4a ), activation of damage sensing signaling pathways and caspase-induced apoptosis [5] [6]. One of the causes of senescence is damage of the telomeres and the lack of the enzyme telomerase activity, leading to the "end-replication problem" [7].
The prototypical molecular changes occurring during senescence include altered morphology, expression of pro-inflammatory cytokines and growth factors. One of the characteristic features of aging mammals is that the function of the immune system decreases as a result of the decline in several components of the immune system (immune senescence), and a shifting to a chronic pro-inflammatory status (the so-called "inflammaging" effect) [11] [12].
Neuroprotective signaling pathways involving neurotrophic factors and cytokines can interfere and delay the effects of aging in experimental models of neurodegenerative disorders [6]. The regulation of cytokines and growth factors through micro-immunotherapy (MI) approach could regulate the neurodegenerative process, counteract immune senescence and delay age-related dysfunctions.
MI is an immunomodulation therapy which uses immune regulators, including cytokines, plant-derived total deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), and specific nucleic acids (SNA ® ) to readjust the immune response.
The active substances, prepared in low doses (LD) and/or ultra-low doses (ULD), are used in sequential formulas developed to treat different acute and chronic diseases.
The aim of the present study was to investigate the effect of one capsule of the micro-immunotherapy medicine (MIM) 2LMISEN ® in a neuronal senescence model.

Hippocampal Neuron Culture
The experiments were performed in accordance to European guidelines for the care and use of laboratory animals (Directive 2010/63/UE) as described by Lilli et al. [13]. For this reason, no authorization was required for this project. Prior to the administration of drugs, animals used to prepare mesencephalic cell cultures were naive. After receipt at the animal house at the latest the day before the sacrifice, pregnant mice were euthanized with CO 2 , according to the authorized procedures. The nervous tissues of interest were then recovered from the embryos and cultured. Central nervous system (CNS) cultures of mice embryos were not subject to any authorization. As described by Harrison [14], mice hippocampal neurons were cultured. Briefly pregnant female mice (Swiss mice; Janvier) of 15 days gestation were euthanized with CO 2 . The foetuses were removed from the uterus and placed in ice-cold medium of Leibovitz 15 (L15; PanBiotech, Germany) containing 2% of Penicillin-Streptomycin (PS; PanBiotech, Germany) and 1% of bovine serum albumin (BSA; PanBiotech, Germany). The hippocampi were dissociated by trypsinisation for 20 min at 37˚C (Trypsin EDTA 1X; PanBiotech, Germany). The reaction was stopped by the addition of Dulbecco's modified Eagle's medium (DMEM; PanBiotech, Germany) containing DNAase I grade II (0.1 mg/ml; Roche Diagnostic, France) and 10% of foetal calf serum (FCS; Invitrogen, USA). Cells were then mechanically dissociated by 3 passages through a 10 ml pipette and then centrifuged at 180x g for 10 min at 4˚C on a layer of BSA (3.5%) in L15 medium. The supernatant was discarded and the cells of pellet were re-suspended in a culture medium consisting of Neurobasal (Invitrogen, USA) supplemented with B27 (2%; Invitrogen, USA), L-glutamine (2 mM; Pan-Biotech, Germany), 2% of PS solution and 10 ng/ml of brain-derived neurotrophic factor (BDNF; PanBiotech, Germany). Viable cells were counted in a Neubauer cytometer using the trypan blue exclusion test. The cells were seeded at a density of 20.000 cells/well in 96 well-plates (pre-coated with poly-D-lysine; Greiner, Austria) and were cultured at 37˚C in a humidified air (95%)/CO 2 (5%) atmosphere. Half of the medium was changed every 2 days with fresh medium. After 12 days of culture, astrocytes are present in the culture and release growth factor allowing neurons differentiation. Hippocampal neuron cultures (6 wells par condition) were treated with MIM (2LMISEN ® ; 11 mM) or vehicle (11 mM

Quantification of p16 INK4a and Caspase 3
Cells were fixed at 15 (control condition), 22, 25 and 27 DIV by a solution of paraformaldehyde 4% (Sigma-Aldrich, USA) for 25 min at room temperature and washed two times with phosphate buffered saline (PBS, PanBiotech, Germany). Cells were then permeabilized and non-specific sites were blocked with a solution of PBS containing 0.1% of saponin (Sigma Aldrich, USA) and 1% of FCS for 15 min at room temperature. Cells were then incubated with primary antibodies p16 INK4a

Investigational Product
The MIM is notified to the Belgian Federal Agency for Medicines and Health Products under notification number 1507CH47F1. As reported by Lilli et al. [13], MI medicines for oromucosal administration are composed of lactose-saccharose pillules impregnated with LD and/or ULD of ethanolic preparations of immune mediators and nucleic acids. Active substances are obtained through a "serial kinetic process" reproduced a defined number of times, consisting of a 1/100 dilution process followed by vertical shaking. Centesimal The pillules contained in one capsule of MIM or vehicle control (380 mg) were dissolved in cell culture media (100 ml). Indeed, the tested lactose-saccharose concentration was 11 mM.

Statistical Analysis
Statistical analyses and graphs have been performed using SAS software 9.4 (SAS

Effect of MIM on p16 INK4a Expression
We showed that an increase of p16 INK4a

Effect of MIM on Caspase 3 Expression
We showed that a statistically significant increase of caspase 3 immunostaining

Discussion
Aging is associated with replicative senescence and increased p16 INK4a  [18]. In fact, the expression of IL-2, in humans and rodents, decreases with age and is associated with immune senescence features and age-related decrease in immunologic function [19].   Specific EGF receptors (EGFR) have been identified in a variety of nerve cells, including the subventricular zone, hippocampus, and cerebellum. The distribution of EGFR expression in the two primary areas of adult neurogenesis suggests that the EGFR could also play a pivotal role in age-related neuronal survival and regeneration [20] [21] [22]. EGF is also expressed in various regions of the CNS, enhancing neurite outgrowth and survival [23]. MIM uses EGF at 10 CH to induce pro-survival and trophic signals.
DHEA is a neurosteroid which has multiple actions in the CNS, such as neuronal differentiation during development [24] and neurogenesis [25]. DHEA has also several neuroprotector effects, protecting hippocampal cells from oxidative stress [26]. Interestingly, DHEA is able to promote neurogenesis and neuronal survival in human neural stem cell cultures in an EGF and leukemia inhibitory factor-dependent manner [27]. MIM uses DHEA at 10 CH to exert neuroprotective effects.
HLA class I molecules are expressed by neurons during development and early adulthood in brain regions, including hippocampus [28] [29]. A coordinated up-regulation of HLA class I pathway expression with hippocampal aging was showed in rats [30]. Several studies also clearly showed that HLA class II up-regulation at the protein level is a prominent immunophenotype of normal brain aging [31] [32]. MIM uses SNA ® targeting HLA class II proteins at 10 CH to regulate their expression and limit overexpression.
TERT is active in the adult rat cerebellum at a higher level than in young rats [33] and promotes tissue regeneration by delaying the entrance of cells into senescence. Moreover, being constitutively expressed in the hippocampus and the olfactory bulbs, TERT is also important for regulating normal brain functions Our results showed that the MIM capsule significantly reduced neuronal senescence and not apoptosis.

Conclusion
The preliminary results of this study allowed to investigate the effect of a single capsule of the MIM sequence in an in vitro model of neuronal senescence. Only one experiment has been performed. Further molecular and mechanistic analyses are required to demonstrate the functioning of the whole MIM sequence in vitro and in vivo.